Skip to main content

Table 3 Univariate and multivariate analysis for OS in gastric cancer patients

From: The prognostic value of preoperative fibrinogen-to-prealbumin ratio and a novel FFC score in patients with resectable gastric cancer

VariablesUnivariate analysisMultivariate analysis
HR (95%CI)P valueHR (95%CI)P value
Gender0.742 (0.505–1.091)0.129  
Age1.270 (0.916–1.761)0.152  
Pathological differention1.191 (0.909–1.562)0.205  
Lymph nodes metastasis5.119 (3.296–7.952)< 0.0011.646 (0.864–3.135)0.130
TNM stage3.147 (2.385–4.151)< 0.0013.564 (1.321–9.618)0.012
Borrmann type1.433 (1.238–1.658)< 0.0010.980 (0.808–1.187)0.834
Tumor size3.587 (2.559–5.028)< 0.0011.958 (1.349–2.842)< 0.001
Body mass index0.884 (0.619–1.264)0.500  
Anemia status1.512 (1.071–2.134)0.0190.971 (0.676–1.394)0.872
CEA1.686 (1.155–2.462)0.0071.422 (0.959–2.107)0.080
CA1991.648 (1.106–2.455)0.0141.043 (0.689–1.579)0.842
FPR2.499 (1.794–3.483)< 0.0011.595 (1.072–2.373)0.021
FAR2.343 (1.673–3.280)< 0.0011.236 (0.829–1.842)0.299
FFC score1.704 (1.446–2.009)< 0.0011.414 (1.189–1.683)< 0.001
  1. OS overall survival; HR hazard ratio; CI confidence interval; CEA carcinoembryonic antigen; CA199 carbohydrate antigen 199; FPR fibrinogen-to-prealbumin ratio; FAR fibrinogen-to-albumin ratio; FFC FPR-FAR-CEA